Role of T cells in a gp91phox knockout murine model of acute allergic asthma
© Banerjee and Henderson; licensee BioMed Central Ltd. 2013
Received: 18 October 2012
Accepted: 29 January 2013
Published: 7 February 2013
Skip to main content
© Banerjee and Henderson; licensee BioMed Central Ltd. 2013
Received: 18 October 2012
Accepted: 29 January 2013
Published: 7 February 2013
Molecular regulation of inflammation, especially, the role of effector cells in NADPH oxidase-mediated redox reactions for producing O2- (superoxide anion) is a critical step. This study explores the roles of macrophages and neutrophils and their cross-talk with extra-cellular matrix components in the light of the role essayed by T cells. Materials and Methods and Treatment: To clarify the role of NADPH oxidase in the pathophysiology of T cell-initiatedmacrophage-associated allergic asthma, we induced allergen dependent inflammation in a gp91 phox −/− SKO (single knockout) and a gp91 phox −/− MMP-12−/− DKO (double knockout) mouse and analysed trafficking and functionality of various cell types, the T cell function and T cell-macrophage interaction being given special emphasis.
Composite asthma symptoms expressed in a more aggravated manner in both the KO (SKO and DKO) mice compared to WT indicating that some redundancy may exist in the response pathways of gp91phox and MMP-12. On the one hand, upregulation in macrophage functions such as proliferation, mixed lymphocyte reaction, and MCP-1 directed chemotaxis, may indicate that a regulatory cross-talk is switched on between T cell and macrophage and on the other, downregulation of respiratory burst response hints at a dichotomy in their signaling pathways. Increased B7.1 but reduced B7.2 and MHC class II expression on KO alveolar macrophages may suggest that a switching on-off mechanism is operative where alteration of co-stimulatory molecule expression selectively activating T cell is a critical step.
T cell mediated functions such as Th2 cytokine secretion, and T cell proliferation in response to OVA were upregulated synchronous with the overall robustness of the asthma phenotype.
As far as cell-cell interaction is concerned, the data is indicative of the existence of a plethora of networks where molecular switches may exist that selectively induce activation and deactivation of regulatory pathways that ultimately manifest in the overall response. gp91 phox and MMP-12 either redundantly or synergistically but not additively, provide a regulatory checkpoint for restricting T cell cross-talk with macrophages and keep excessive tissue damage and ECM degradation during acute allergic inflammation under control.
The production of superoxide anions (O2-) by neutrophils and other phagocytes is an important step in our body's innate immune response. [1, 2]. These act as microbicidal agents and kill invading micro-organisms either directly or through the activation of proteases [3, 4]. O2- is produced by the NADPH oxidase, a multi-protein enzyme complex, which is inactive in resting phagocytes, but becomes activated after interaction of the phagocyte with pathogens and their subsequent engulfment in the phagosome . Defects in the function of the NADPH oxidase result in a severe immunodeficiency, and individuals suffering from CGD (chronic granulomatous disease), a rare genetic disorder that is caused by mutations in NADPH oxidase genes, are highly susceptible to frequent and often life-threatening infections by bacteria and fungi [6, 7].
NADPH oxidase, the primary source of reactive oxygen species is a strong candidate for the development of therapeutic agents to ameliorate inflammation and end-organ damage [8, 9]. Additionally, the study of cytochrome isolated from patients with X-linked CGD has contributed to our current understanding of its function [10, 11].
Involvement of the gp91phox subunit in oxidative burst response by PMNs as well as Macrophages is not clear. Macrophages use a membrane-associated NADPH oxidase to generate an array of oxidizing intermediates. In some studies, it has been demonstrated that oxidants potently and efficiently inactivate matrilysin (MMP-7) by cross-linking adjacent tryptophan-glycine residues within the catalytic domain of the enzyme. These in vitro observations suggest that MMP inactivation can occur on or near phagocytes that produce both MMPs and reactive intermediates. In the absence of reactive intermediates, unrestrained proteolytic activity might lead to detrimental tissue damage. Indeed, inherited deficiency of gp91 phox , a phagocyte-specific component of the NADPH oxidase required for oxidant production, and targeted deletion of its mouse homologue result in granuloma formation and excessive tissue destruction .
This study addresses for the first time the relationship between gp91phox and MMP-12 in the development of T cell mediated acute allergic asthma in a mouse model using genetic knockout mice, gp91phox−/− which will be referred to as NOX−/− or SKO and MMP-12-NOX DKO. The study focuses on the cross-talk between T cells and macrophages and shows that gp91phox most likely has a regulatory role in the onset and maintenance of the composite asthma phenotype in mouse and deletion of gp91phox may alter expression of co-stimulatory/co-inhibitory molecules B7.1 (increased) and B7.2 (decreased) and MHCII expression (increased) which may explain the mechanism by which macrophages despite increased migration to the inflammatory foci in vivo and increased migration in a chemotaxis chamber to MCP-1, and enhanced proliferation to syngeneic or allogeneic stimulus in vitro, fail to execute oxidative burst response. MMP-12 seems to be either redundant, not contributing to the overall asthma phenotype or has a synergistic (not additive) role in the process.
Both gp91phox−/− mice [13, 14] were on a C57Bl/6J background and had been outcrossed and then intercrossed for three generations to generate animals deficient in both genes. C57BL6 mice (Taconic) were used as the control group and are called wildtype. In total the following number of animals were used in each group: WT (14), NOX−/− (14), MMP-12NOX−/−(16) in the control group and WT (16), NOX−/− (15), MMP-12NOX−/−(14).
Mice were sensitized and later challenged with OVA (Thermo Scientific Pierce Protein Research Products, Rockford, IL) as described previously .
The mouse underwent exsanguination by intra-orbital arterial bleeding and cells, obtained by bronchoalveolar lavage and those from lung parenchyma (obtained by lung mincing and digestion was performed after lavage as described previously  with 100u/ml collagenase for 1 hr at 37°C, and filtered through a 60# sieve (-Aldrich Corporation, St. Louis, Sigma) were evaluated after air drying, by staining with Wright-Giemsa (Biochemical Sciences Inc, Swedesboro, NJ) and their differential count was taken under a light microscope at 40X magnification. Cell number refers to that obtained from lavage of both lungs/mouse. In addition, cells from hemolysed peripheral blood (PB), bone marrow( BM), bronchoalveolar lavage (BAL), lung parenchyma (LP), spleen, mesenteric lymph nodes (MLN), cervical lymph nodes (CLN), axillary lymph nodes (LNX) and inguinal lymph nodes (LNI) were analyzed on a FACSCalibur (BD Immunocytometry Systems, San Jose, CA) by using the CELLQuest program. Staining was performed by using antibodies conjugated to fluorescin isothiocyanate (FITC), phycoerythrin (PE), allophucocyanin (APC), Peridinin Chlorophyll Protein (Per CP-Cy5.5) and Cy-chrome ( PE-Cy5 and PE-Cy7). The following BD pharmingen (San Diego, CA) antibodies were used for cell surface staining : APC-conjugated CD45 (30F-11), FITC-conjugated CD3(145-2C11), PE-Cy5 conjugated CD4 (RM4-5),PE-conjugated CD45RC (DNL-1.9), APC-conjugated CD8(53–6.7), PE-Cy5 conjugated B220 (RA3-6B2), FITC-conjugated IgM, PE-conjugated CD19 (ID3), PE-conjugated CD21(7G6), FITC-conjugated CD23 (B3B4), APC-conjugated GR-1(RB6-8C5), and PE-conjugated Mac1(M1/70). PE-Cy5 conjugated F4/80 (Cl:A3-1(F4/80)) was obtained from Serotec Ltd., Oxford, UK. PE-conjugated anti-α4 integrin (PS2) and anti-VCAM-1(M/K-2) was from Southern Biotechnology, Birmingham, Ala. Irrelevant isotype-matched antibodies were used as controls.
Chemotaxis assay was performed with 10 million macrophages pooled from 4 mice/experimental group. Macrophages were prepared by adhering BALf cells in high glucose medium for 2 hours followed by detachment by mechanical scraping and resuspension in Phenol red-free high glucose DMEM (Gibco) with 5% FBS with 0.5μg/ml Calcein-AM (1:2000 dilution) and incubation for 20 min at 37°C. MCP-1 at dilutions ranging from 0.1-25mM were used and 15 mM was taken to be the optimum dose. 96 well Neuroprobe CTX plates (Chemicon, Temecula,CA) were used. 29μl MCP-1 (15mM) was added as a single convex drop and the polycarbonate filter placed gently over it and incubated at 37°C for 30 min. Cell suspension was added in designated slots over the filter membrane also in 29μl volume. The chamber was incubated at 37°C in humidified CO2 incubator for 2h. Excess cells were wiped off with kimwipes at the end of the incubation period. Migrated cells were quantified by fluorescence (excitation at 488 nm, emission at 520 nm) using a Victor 3V (Perkin Elmer laboratories) using a Wallac1420 software.
Alveolar leukocytes (0.5 × 106 cells) were stained with F4/80-Cy-Chrome and Gr1-APC for 30 min on ice, washed in PBS, warmed up at 37°C for 5 min and loaded with 5mM dihydrorhodamine 123 (Molecular Probes, Eugene, OR). After 10 min at 370C, cells were split in two equal aliquots, and PMA (Sigma, St. Louis, MO) was added to one aliquot at final concentration of 1mM. After 10 min incubation cells were washed in ice-cold PBS and immediately subjected to FACS analysis. Cells were gated on neutrophils (Gr1hi), or monocyte/macrophages (F4/80+) and percentage of cells positive for dihydrorhodamine 123 fluorescence with or without PMA treatment was determined for each gate.
List of mouse primers for real time PCR
House- keeping genes
Growth factor genes
Statistical differences among samples were tested by Student t test. P value less than 0.05 was considered statistically significant.
Enhanced cytokine gene expression in KO lung
Alteration in growth factor genes in KO lung post-OVA
Deletion of gp91phox results in enhancement of composite asthma phenotype in mouse [17–20]. Double deletion of gp91phoix and MMP-12, a critical enzyme for phagocyte associated inflammation results in no alteration of the phenotype generated in the single deletion of gp91phox. Recruitment index (Table 1) shows statistically significant increase in recruitment of T cells in BALf of KO mice compared to WT but not in lung, while in lung parenchyma of KO mice, macrophage, PMN and basophils are preferentially upregulated compared to WT. Overall systemic response, inflammatory recruitment from blood to inflammation in lung is more in KO mice compared to WT (Table 2). Selective upregulation of both cytokine protein and cytokine mRNA of IL-13 indicates a preferential T cell mediated pathway which is unregulated in the gp91phox knockout as well as the DKO mouse. (Table 3, Figure 1) Surprisingly, there was downregulation of TGFβ which may indicate that in keeping with decreased iNOS expression and the consequent shift in macrophage phenotype to M1 (killer) from M2 (healer), TGFβ expression was also downregulated indicating a possible regulatory role for gp91phox in the development of Th2 phenotype and that deletion of the same disrupts the control or moderating effect involving cross-talk between T cells. Consequently, the phagocytes downstream that need NADPH enzyme for the respiratory burst response and proliferation are affected. Increased chemotaxis to MCP-1 may be explained by the increased expression of MCP-3. Upregulation of MMP-12 in gp91phox−/− both before and after OVA, may indicate a compensatory mechanism in the regulation of Th2 response (Table 4). Downmodulation of genes for MMP-7, 9, 10, and 28 in post-OVA SKO and DKO lungs may indicate that these metalloproteases which are also known regulators of inflammation, when downregulated in a situation of gp91phox deletion, may have disrupted a critical control mechanism on the development of Th2 mediated inflammation in lung.(Figure 2 and 3) T cells in SKO and DKO mice were functionally competent as revealed by functional tests. (Figure 4) Contradictory up- and down-modulation data of different functional responses, viz. oxidative burst response by a heterogeneous population of phagocytes in the lung and directed migration to MCP-1 gradient in a chemotaxis assay done with alveolar macrophages, indicate a dichotomy in the signaling of the same cells when different stimuli are present. (Figure 5 and 6) There was unregulated oxidative burst response (Figure 5), enhanced chemotaxis to MCP-1(Figure 6) and increased MLR (both syngeneic and allogeneic) (Figure 7), probably indicating relation to the role of these molecules in the cross-talk between T cells and alveolar macrophages, a phenomenon which can account for the “unregulated” recruitment of KO T cells to the lung interstitium which is what finally dictates development of lung inflammation in Th2 mediated allergy [16, 21–25]. The overall Th2 response was enhanced possibly due to a lack of control over T cell: APC cross-talk in the KO mice as shown by the results of the MLR assay. Increased B7.1 but decreased B7.2 and MHCII expression may provide possible mechanistic insights into the regulatory function of gp91phox and MMP-12 [26, 27]. iNOS upregulation has always been construed as indicator of heightened inflammation by the participating cells [28–30]. Recruitment of B cells, monocytes, neutrophils and basophils are increased in lungs of both knockout mice compared to post-OVA wildtype while that of T cells, neutrophils and basophils in BALf are increased in the knockout vs. the OVA-treated wildtype (Table 2). MMP-12 controls migration of monocytes and macrophages to inflammatory sites and airway remodeling by degrading ECM proteins . It is supposed to have a protective effect in emphysema . B7.1, a co-stimulatory signal necessary for the activation of T cells, are expressed on cell surface by B cells, dendritic cells and macrophages, the so-called antigen presenting cells. It is associated with activation of cell mediated response, especially Th2 response. At baseline, they are not expressed but upon activation are upregulated. In our model, upregulation of B7.1 but downregulation of B7.2 and MHCII shows a possible mechanism by which gp91phox and MMP-12, may synergistically regulate Th2 responsiveness and deletion of the same possibly disrupts this pathway. Mature T lymphocytes become activated to perform their effector functions when stimulated by appropriate APC bearing MHC class I or class II molecules. So antagonistic alterations in B7 family of receptors in the acute asthma pathway may indicate a definite role for either gp91phox or both gp91phox and MMP-12 in controlling the co-stimulatory activating pathway in T cell activation in Th2 response.
gp91phox specifically may be regulating IL-13 gene activation in the lung tissue as well as translation into protein secreted into the airways. This may be associative.
The direction of stimulus to → response seems to be T cells to →macrophages and not vice versa. In other words, gp91phox alone or gp91phox and MMP-12 together regulate/translate T cell directive to macrophages for clinical manifestation of the Th2-initiated, macrophage-mediated allergic phenomenon.
Downmodulation of respiratory burst response in neutrophils and macrophages isolated from lung but upregulation of MCP-1 directed chemotaxis by alveolar macrophages collected from lung interstitium and airways, indicate a dichotomy in the role of gp91phox in controlling macrophages responses to divergent stimuli in a cell specific or tissue specific manner. Upmodulated B7.1expression but downmodulateded B7.2 and MHC class II expression in KO alveolar macrophages may indicate that alteration of co-stimulatory molecule expression may give critical signals for T cell activation.
There seems to be some redundancy in their regulatory capacity for Th2 activation but gp91 phox and MMP-12 do seem to provide a regulatory checkpoint (possibly sequentially but not additively) to restrict T cell cross-talk with macrophages and keeps excessive tissue damage and ECM degradation during acute allergic inflammation under control.
Bronchoalveolar lavage fluid
Hematoxylin and Eosin
Whole body plethysmography
Reactive oxygen species
T cell receptor
This work was supported by National Institute of Health grants 62–9208 and 62–9538 (WRH). We thank J. W. Heinecke for the Cybb−/− mice that were bred in his laboratory by Z. Sagawa and R. Norris for initial editing of this manuscript. The author also acknowledges contribution of Tim Burkland, Ph.D. and Eman Sadoun, Ph.D. respectively for carrying out the real time PCR analysis of the MMP and RGS genes. Some confirmatory assays were performed in the ERB lab at the University of Calcutta, India and editing of the final manuscript done by fellows of ERB lab- Kaustab Mukherjee, Debalina Mukhopadhyay, Shankha Subhra Chatterjee, Gaytri Datta, Anjan Ghosh and Anisha Polley. Finally I wish to thank Dr. Umesh Singh and my children Urbi, Adit and baby Arit for their support all the way.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.